Celgene (CELG ) Tops Q2 EPS by 4c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Celgene (CELG) PT Lifted to $167 at Nomura on Building Momentum
July 24, 2015 10:40 AM EDTNomura Securities analyst M. Ian Somaiya reiterated his Buy rating and boosted his price target on Celgene (NASDAQ: CELG) to $167.00 (from $165.00) following 2Q earnings, which saw largely in-line revenue, but an EPS beat on continued operating leverage.
Somaiya commented, "We believe... More
Celgene (CELG) PT Lifted to $150 at Cowen Amid Solid Q2
July 23, 2015 11:19 AM EDTCowen analyst Eric Schmidt bumped his price target on Outperform-rated Celgene (NASDAQ: CELG) to $150.00 (from $146.00) following solid Q2 results.
Schmidt commented, "Celgene reported Q2 sales of $2.254B (+22% Y/Y) and non-GAAP EPS $1.17 (+30% Y/Y, excluding 1x gain of $0.06), in-line with its... More
